Literature DB >> 1818058

Determination of imipramine, desipramine and their hydroxy metabolites by reversed-phase chromatography with ultraviolet and coulometric detection.

J P Foglia1, D Sorisio, J M Perel.   

Abstract

A reversed-phase high-performance liquid chromatographic method is described which analyzes imipramine, desipramine and their corresponding 2-hydroxy metabolites with sequential ultraviolet and coulometric detection from a single common extraction step, so that a wider dynamic range of plasma concentrations can be measured requiring smaller sample volumes. Applicability is broader including single-dose pharmacokinetic studies as well as steady-state concentrations. The extraction procedure gives excellent recoveries for imipramine, desipramine and their metabolites (mean +/- S.D.): ultraviolet detection, imipramine 99.5 +/- 0.68%, desipramine 100 +/- 0.0%, 2-hydroxyimipramine 97.8 +/- 3.5% and 2-hydroxydesipramine 93.1 +/- 4.22%; coulometric detection, imipramine 97.5 +/- 1.9%, desipramine 98.3 +/- 1.2%, 2-hydroxyimipramine 90.3 +/- 4.0% and 2-hydroxydesipramine 86.6 +/- 7.5%.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1818058     DOI: 10.1016/0378-4347(91)80489-y

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

Review 1.  Clinical pharmacokinetics of drugs used to treat urge incontinence.

Authors:  David R P Guay
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Imipramine and 2-hydroxyimipramine: comparative cardiotoxicity and pharmacokinetics in swine.

Authors:  B G Pollock; J M Perel
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Measurement and pharmacokinetic analysis of imipramine and its metabolite by brain microdialysis.

Authors:  Y Sato; S Shibanoki; M Sugahara; K Ishikawa
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.